General

Tesla Inc (NASDAQ: TSLA) CEO Elon Musk on Tuesday warned of population collapse once again, an event that, he has said in the past, could potentially be the greatest risk to the future of civilization. What Happened: 50-year-old Musk, who is raising seven children, said the U.S. birth rate has...

Sam Bankman-Fried, the founder and CEO of cryptocurrency exchange FTX, is willing to spend over $100 million on his preferred candidate in the 2024 election. What Happened: In a recent podcast interview with Jacob Goldstein, Bankman-Fried said he had a “soft cap” of $1 billion that he...

A group of legacy operators has formed a coalition called Unified Legacy Operators Council (UNLOC) from New York State, in order to compel regulators to take the underground industry seriously. The group, with about 25 members, expressed that "legacy entrepreneurs have deep connections in the...

Jay Leno is known for hosting "The Tonight Show" for years and as a comedian. Outside of the world of entertainment, Leno is also known as a car enthusiast and the collector of hundreds of rare automobiles. Leno may soon be known as a “truck guy” instead of a “car guy...

While the great majority of U.S presidents have been wealthy, the coveted role in the Oval Office doesn’t necessarily translate to big dollars. Some of the presidents with the lowest net worth came from humble beginnings: Abraham Lincoln, Andrew Johnson and James Garfield were born in...

One hedge fund manager took to Twitter Inc (NYSE: TWTR) on Tuesday to express serious inflation concerns and the potential consequences of inaction.  What Happened: Pershing Square's Bill Ackman called out the Federal Reserve for its inability to recapture investor...

Tomatoes are known for being sweet and juicy, as well as full of antioxidants. If that's not enough, scientists have now developed a way to make them even healthier. What Happened: Researchers have figured out how to increase the level of vitamin D3 in the fruit (that’s...

Every week, Benzinga conducts a survey to collect sentiment on what traders are most excited about, interested in or thinking about as they manage and build their personal portfolios. This week we posed the following question to over 1,000 Benzinga visitors on cryptocurrency investing: If you had $...

Cingulate Inc. (NASDAQ: CING) has completed enrollment in its study to determine the appropriate formulation of its third asset, CTx-2103, for the management of anxiety-related disorders. The early stage study has enrolled 12 patients after the initiation early this month. Cingulate...

Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) has dosed the first patient in the Phase 3 COMET-2 study to evaluate AR-15512 ophthalmic solution as a treatment for the signs and symptoms of dry eye disease (DED). This study is the first of three trials in the Phase 3 registrational program for AR-15512...

This article was originally published in March 2022.  The International Federation of the Phonographic Industry reported Tuesday that global recorded music revenues grew 18.5% in 2021, with much of the growth driven by paid subscription streaming. The report shows total revenues for 2021...

This article was originally published in March 2022.  Easter eggs are those hard-to-find references hidden in movies by directors and producers for keen-eyed fans to uncover and enjoy. In 1937, Walt Disney Co (NYSE: DIS) released "Snow White and the Seven Dwarfs." It was...

SVB Leerink is initiating coverage of HilleVax Inc (NASDAQ: HLVX) shares with an Outperform rating and a $30 price target.  The analyst believes the company’s potentially first-in-class infant norovirus vaccine HIL214 represents a uniquely de-risked opportunity....

Stellantis NV (NYSE: STLA) and Samsung SDI have signed a binding, definitive agreement to establish an electric-vehicle battery manufacturing facility in Kokomo, Indiana. The joint venture will invest more than $2.5 billion (€2.3 billion) and create 1,400 new jobs in...

SVB Securities initiated coverage on Argenx SE (NASDAQ: ARGX) with an Outperform rating and a $404 price target. Argenx's Vyvgart (efgartigimod) is a neonatal Fc-Receptor (FcRn) antagonist that selectively reduces IgG levels and has the potential to address numerous IgG-...